Immune Thrombocytopenic Purpura ICD 10 Codes – Coding & Billing Solutions

Coding & Billing Solutions > Blog > ICD 10 Codes > Immune Thrombocytopenic Purpura ICD 10 Codes – Coding & Billing Solutions

Immune Thrombocytopenic Purpura ICD 10 Codes – Coding & Billing Solutions

The following is coding for Immune thrombocytopenic purpura ICD-10 Codes

2024 ICD-10-CM Diagnosis Code D69.3

  • D69.3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2024 edition of ICD-10-CM D69.3 became effective on October 1, 2023.
  • This is the American ICD-10-CM version of D69.3 – other international versions of ICD-10 D69.3 may differ.

Applicable To

  • Hemorrhagic (thrombocytopenic) purpura
  • Idiopathic thrombocytopenic purpura
  • Tidal platelet dysgenesis

The following code(s) above D69.3 contain annotation back-references

that may be applicable to D69.3:

  • D50-D89 – Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
  • D69 Purpura and other hemorrhagic conditions

Approximate Synonyms

  • Acute idiopathic thrombocytopenic purpura
  • Chronic idiopathic thrombocytopenic purpura
  • Idiopathic thrombocytopenia purpura (itp)
  • Idiopathic thrombocytopenic purpura
  • Idiopathic thrombocytopenic purpura, chronic
  • Purpura, idiopathic thrombocytopenia, acute

Clinical Information

  • A condition in which platelets (blood cells that cause blood clots to form) are destroyed by the immune system. The low platelet count causes easy bruising and bleeding, which may be seen as purple areas in the skin, mucous membranes, and outer linings of organs.
  • An autoimmune disorder in which the number of circulating platelets is reduced due to their antibody-mediated destruction. Itp is a diagnosis of exclusion and is heterogeneous in origin.
  • Bleeding or bruising tendency due to low platelet level
  • Thrombocytopenia occurring in the absence of toxic exposure or a disease associated with decreased platelets. It is mediated by immune mechanisms, in most cases immunoglobulin g autoantibodies which attach to platelets and subsequently undergo destruction by macrophages. The disease is seen in acute (affecting children) and chronic (adult) forms.

ICD-10-CM D69.3 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):

  • 813 Coagulation disorders

Convert D69.3 to ICD-9-CM

Code History

    2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)

    2017 (effective 10/1/2016): No change

    2018 (effective 10/1/2017): No change

    2019 (effective 10/1/2018): No change

    2020 (effective 10/1/2019): No change

    2021 (effective 10/1/2020): No change

    2022 (effective 10/1/2021): No change

    2023 (effective 10/1/2022): No change

    2024 (effective 10/1/2023): No change

Code annotations containing back-references to D69.3:

  • Type 1 Excludes: D69.0

Diagnosis Index entries containing back-references to D69.3:

  • Dysgenesis

  tidal platelet D69.3

  • Frank’s essential thrombocytopenia D69.3
  • Hemorrhage, hemorrhagic (concealed) R58

        purpura D69.3 (primary)

  • Purpura D69.2

        hemorrhagic, hemorrhagica D69.3

        idiopathic (thrombocytopenic) D69.3

        thrombocytopenic D69.49

            hemorrhagic D69.3

            idiopathic D69.3

            immune D69.3

        immune thrombocytopenic D69.3

  • Thrombocytopenia, thrombocytopenic D69.6

        primary NEC D69.49

            idiopathic D69.3

        essential D69.3

        idiopathic D69.3

  • Werlhof’s disease D69.3